KamranMahalatiMD

PubMed

• Formation of Biologic Plug and Patch Mesh for Use in Perforated Femoral Hernia.
  Michael P Stolz, James G Chambers, Kamran Mahalati> ;The American Surgeon. 2023 Dec 1
• 92 citations
  Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption Profiling
  Catherine M. Clase, Kamran Mahalati, Bryce A. Kiberd, Joseph Lawen, Kenneth A. West, Albert D. Fraser, Philip Belitsky> ;American Journal of Transplantation. 2002 Sep 1
• 64 citations
  A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.
  Vivian C. McAlister, Kamran Mahalati, Kevork M. Peltekian, Albert D. Fraser, Allan S. MacDonald> ;Therapeutic Drug Monitoring. 2002 Jun 1
• 135 citations
  Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation: A Prospective Study
  Kamran Mahalati, Philip Belitsky, Kenneth A. West, Bryce A. Kiberd, Albert D. Fraser, Ingrid S. Sketris, A. S. MacDonald, Vivian C. McAlister, Joseph Lawen> ;Journal of the American Society of Nephrology. 2001 Apr 1
• 209 citations
  Clinical pharmacokinetics of sirolimus.
  Kamran Mahalati, Barry D. Kahan> ;Clinical Pharmacokinetics. 2001 Jan 1
• 96 citations
  Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience.
  Javier Dominguez, Kamran Mahalati, Bryce A. Kiberd, Vivian C. McAlister, Allan S. MacDonald> ;Transplantation. 2000 Oct 27
• 119 citations
  Is routine ureteric stenting needed in kidney transplantation? A randomized trial.
  Javier Dominguez, Catherine M. Clase, Kamran Mahalati, Allan S. MacDonald, Vivian C. McAlister, Philip Belitsky, Bryce A. Kiberd, Joseph Lawen> ;Transplantation. 2000 Aug 27
• 18 citations
  Pharmacological surrogates of allograft outcome.
  Kamran Mahalati, Barry D. Kahan> ;Annals of Transplantation. 2000 Jun 9
• 18 citations
  IS 3-HOUR CYCLOSPORINE BLOOD LEVEL SUPERIOR TO TROUGH LEVEL IN EARLY POST-RENAL TRANSPLANTATION PERIOD?
  Kamran Mahalati, Joseph Lawen, Bryce A. Kiberd, Philip Belitsky> ;The Journal of Urology. 2000 Jan 1
• 321 citations
  Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early afte...
  Kamran Mahalati, Philip Belitsky, Ingrid S. Sketris, Kenneth A. West, Romauld Panek> ;Transplantation. 1999 Jul 15
• 9 citations
  Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve.
  Philip Belitsky, Kamran Mahalati, Kenneth A. West, Ingrid S. Sketris> ;Transplantation Proceedings. 1999 May 1
• 5 citations
  Methotrexate tolerance in patients with ileal conduits and continent diversions.
  Sandy Srinivas, Kamran Mahalati, Fuad S. Freiha> ;Cancer. 1998 Mar 15
• A pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine a combination therapy.
  Mahalati, K., Kahan, B. D.> ;Transplant Proc. 2001 Nov 01
• Sirolimus permits steroid withdrawal from a cyclosporine regimen.
  Mahalati, K., Kahan, B. D.> ;Transplant Proc. 2001 Feb 01
• A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than t...
  Mahalati, K., Belitsky, P., West, K., Kiberd, B., MacDonald, A., McAlister, V., Lawen, J.> ;Transplant Proc. 2000 Jun
• Multicentricity in renal cell carcinoma.
  Bilen, C. Y., Mahalati, K., Ozen, H., Aki, F. T., Ilyas, C., Kendi, S.> ;Int Urol Nephrol. 1999
• Sirolimus-tacrolimus combination immunosuppression.
  McAlister, V. C., Gao, Z., Peltekian, K., Domingues, J., Mahalati, K., MacDonald, A. S.> ;Lancet. 2000 Jan 29
• Persistant pre-eclampsia post partum with elevated liver enzymes and hemolytic uremic syndrome.
  Mahalati, K., Dawson, R. B., Collins, J. O., Bell, W. R., McCrae, K. R., Martin, J. N.> ;J Clin Apher. 1999
• Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
  Mahalati, K., Dawson, R. B., Collins, J. O., Mayer, R. F.> ;J Clin Apher. 1999
• The management of brain metastasis in nonseminomatous germ cell tumours.
  Mahalati, K., Bilen, C. Y., Ozen, H., Aki, F. T., Kendi, S.> ;BJU Int. 1999 Mar
• Characteristics of 73 patients, 1984-1993, treated by plasma exchange for Guillain-Barre syndrome.
  Mahalati, K., Dawson, R. B., Collins, J. O., Lietman, S., Pearlman, S., Gulden, D.> ;J Clin Apher. 1997
• Ureteroscopic management of lower ureteral stones: two years'' experience.
  Bilen, C. Y., Mahalati, K., Sahin, A., Tekin, I., Ozen, H., Remzi, D.> ;Int Urol Nephrol. 1997
• A modified BEP protocol: reduction of hospitalization without reducing the efficacy.
  Ozen, H., Tekin, I., Sahin, A., Mahalati, K., Remzi, D.> ;Urol Int. 1997
• Durable remissions following prolonged plasma exchange in thrombotic thrombocytopenic purpura.
  Dawson, R. B., Brown, J. A., Mahalati, K., Sapsiri, S., Pearlman, S., Gulden, D., Bilenki, L., Wenk, R. E.> ;J Clin Apher. 1994
• [Mesoblastic nephroma in adults: a clinical case].
  Mahalati, K., Sahin, A., Ozen, H., Bozdogan, O., Cila, A., Ruacan, S.> ;Bull Cancer. 1994 Nov
• Join now to see all